Virtual Tour- Company Profile

Gibraltar Laboratories’ eminent scientific staff and stellar track regulatory compliance record makes it preferred 90% of the largest pharmaceutical and medical device companies. Each year the accuracy and completion of documentation is much greater than 95%. Gibraltar was one of first and is still one of only a few labs in the country currently ISO 17025 Biological certified. Gibraltar has been inspected by FDA and found to be in compliance with many of the European regulatory agencies.

Education is a key quality attribute valued by Gibraltar and its staff is routinely comprised with 20% at the PhD’s, Master’s Degree level Scientists. With labs in New Jersey and a staff of fifty scientists (including.), companies turn to Gibraltar Laboratories for the most exacting research, testing, and scientific consulting.

Customer satisfaction and staff responsiveness are part of Gibraltar’s mission. From 2012 through 2016 it has received a greater than 90% approval rating from its clients and has received numerous awards based on blind customer feedback

From a historical perspective Gibraltar is one of the most established firms being led continuously by the Prince family. Gibraltar Laboratories Inc. was founded in 1970 by Dr. Herbert Prince, co-discoverer of a cure for Hodgkin’s disease (Procarbazine) and also involved with the team that developed the drug BACTRIM (TMP-Sulfa) now used extensively in the treatment of MRSA infections. Gibraltar Laboratories, Inc. (GBL) has over 40 years of exemplary service to its credit.

Dr. Daniel Prince is president of Gibraltar Laboratories Inc. He has led the Company’s expansion and growth since 1987 taking it from a small to medium sized internationally respected independent firm. He has developed a strong group of leaders to sustain the future growth of the company including his son, Derek.